Management of toxicities from antibody-drug conjugates. Read more about Management of toxicities from antibody-drug conjugates.
Biomarkers and novel PET imaging to detect neuroendocrine prostate cancer. Read more about Biomarkers and novel PET imaging to detect neuroendocrine prostate cancer.
Addressing unmet need in the management of patients with ER+/HER2-, ESR1-mutated metastatic breast cancer: clinician's perspective. Read more about Addressing unmet need in the management of patients with ER+/HER2-, ESR1-mutated metastatic breast cancer: clinician's perspective.
Highlights from the 2023 American Society of Clinical Oncology Annual Meeting: breast cancer. Read more about Highlights from the 2023 American Society of Clinical Oncology Annual Meeting: breast cancer.
New staging systems in nonmetastatic prostate cancer. Read more about New staging systems in nonmetastatic prostate cancer.
Addressing cardiovascular complications of BTK inhibitors. Read more about Addressing cardiovascular complications of BTK inhibitors.
The evolving role of combination systemic therapies in hepatocellular carcinoma. Read more about The evolving role of combination systemic therapies in hepatocellular carcinoma.
When to use somatic tumor testing in prostate cancer. Read more about When to use somatic tumor testing in prostate cancer.
The use of neoadjuvant therapy to further personalize breast cancer treatment. Read more about The use of neoadjuvant therapy to further personalize breast cancer treatment.
Highlights in metastatic breast cancer from the 2020 San Antonio Breast Cancer Symposium: commentary. Read more about Highlights in metastatic breast cancer from the 2020 San Antonio Breast Cancer Symposium: commentary.
